BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15368547)

  • 1. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia.
    Hijiya N; Metzger ML; Pounds S; Schmidt JE; Razzouk BI; Rubnitz JE; Howard SC; Nunez CA; Pui CH; Ribeiro RC
    Pediatr Blood Cancer; 2005 Jan; 44(1):63-9. PubMed ID: 15368547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors related to prognosis and relapse in acute myelomonocytic and monocytic leukemias (M4 and M5)].
    Koyama A; Shirakawa C; Masaki H; Horiuchi F; Hamazaki H; Fujimoto T; Irimajiri K; Horiuchi A
    Rinsho Ketsueki; 1990 Nov; 31(11):1787-93. PubMed ID: 2287062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
    Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
    Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between acute pancreatitis and systemic inflammation response syndrome in children].
    Li N; Wang XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):715-8. PubMed ID: 19102837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia.
    Yang L; Cao L; Yang M; Tang D; Kang R; Min X; Zhu S; Yu Y
    Oncol Rep; 2013 Apr; 29(4):1459-66. PubMed ID: 23404246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between expression of CD56/NCAM and severe leukostasis in hyperleukocytic acute myelomonocytic leukaemia.
    Novotny JR; Nückel H; Dührsen U
    Eur J Haematol; 2006 Apr; 76(4):299-308. PubMed ID: 16519701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
    Tallman MS; Kim HT; Paietta E; Bennett JM; Dewald G; Cassileth PA; Wiernik PH; Rowe JM;
    J Clin Oncol; 2004 Apr; 22(7):1276-86. PubMed ID: 14970186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
    Inaba H; Fan Y; Pounds S; Geiger TL; Rubnitz JE; Ribeiro RC; Pui CH; Razzouk BI
    Cancer; 2008 Aug; 113(3):522-9. PubMed ID: 18484648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis.
    Jo A; Tsukimoto I; Ishii E; Asou N; Mitani S; Shimada A; Igarashi T; Hayashi Y; Ichikawa H
    Br J Haematol; 2009 Mar; 144(6):917-29. PubMed ID: 19120366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of acute lymphoblastic leukaemia following acute myeloid leukaemia.
    Chevallier P; Al Nawakil C; Vigouroux S; Talmant P; Harousseau JL; Garand R
    Leuk Res; 2008 Jun; 32(6):1001-3. PubMed ID: 18093650
    [No Abstract]   [Full Text] [Related]  

  • 15. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
    Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary isolated myeolosarcoma in childhood].
    Reinhardt D; Pekrun A; Lakomek M; Ritter J; Creutzig U
    Klin Padiatr; 1999; 211(4):245-9. PubMed ID: 10472558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The morphological subcategories of acute monocytic leukemia (M5a and M5b) share similar immunophenotypic and cytogenetic features and clinical outcomes.
    Villeneuve P; Kim DT; Xu W; Brandwein J; Chang H
    Leuk Res; 2008 Feb; 32(2):269-73. PubMed ID: 17689610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure.
    Leithead JA; Ferguson JW; Bates CM; Davidson JS; Lee A; Bathgate AJ; Hayes PC; Simpson KJ
    Gut; 2009 Mar; 58(3):443-9. PubMed ID: 19001057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M4 and M5 acute myeloid leukaemias display a high sensitivity to Bortezomib-mediated apoptosis.
    Riccioni R; Senese M; Diverio D; Riti V; Buffolino S; Mariani G; Boe A; Cedrone M; Lo-Coco F; Foà R; Peschle C; Testa U
    Br J Haematol; 2007 Oct; 139(2):194-205. PubMed ID: 17897295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.